Open access
Dual JAK1 and JAK2 Mutations in Philadelphia Chromosome–Like ALL: A Case Report and the Impact of Implementing NGS in a Resource- Limited Setting
Abstract
This article does not have an abstract
Similar papers
Open access
Oct 2026
Metronomic decitabine with venetoclax offers a patient-centered frontline therapeutic approach for TP53-mutated complex-karyotype myeloid neoplasms.
Not available.
L. Walsh, Royce P. Lee, Joanathan Pan et al.
· Haematologica · 0 citations
Open access
Oct 2026
Carriers of POLG1 Variants Require a Comprehensive Genetic and Clinical Examination
<jats:p>None.</jats:p>
J. Finsterer
· International Journal of Adv... · 0 citations
Open access
Oct 2026
Neoplasms and Chemotherapy Side Effects in MELAS Patients are Likely Associated with the Underlying Genetic Defect
<jats:p>None.</jats:p>
J. Finsterer, Sounira Mehri, C. Scorza et al.
· International Journal of Adv... · 0 citations
Metronomic decitabine offers a patient-centered frontline therapeutic approach for TP53 -mutated complex-karyotype myeloid neoplasms
Jonathan A. Webster, Lukasz P. Gondek, Mark J. Levis et al.
· 0 citations
Oct 2026
Third-generation tyrosine kinase inhibitor combined with pediatric-like intensive chemotherapy induced complete molecular remission in a rare case of de novo Philadelphia-positive T-ALL with p230 isoform
,
Lin-Juan Wang, Yun-Tao Liu, Hui-Hui Yang et al.
· Blood Science · 0 citations
Open access
Sep 2026
Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Not available.
Ji-Mo Jian, Zi-Jing Ye, Hong-Yuan Hao et al.
· Haematologica · 0 citations